Monday, 7 June 2021

Protagonist Therapeutics to Host Investor Conference Call and Webcast to Discuss Updated Phase 2 Rusfertide Results in Polycythemia Vera as Presented at EHA 2021 - Yahoo Finance

Protagonist Therapeutics to Host Investor Conference Call and Webcast to Discuss Updated Phase 2 Rusfertide Results in Polycythemia Vera as Presented at EHA 2021  Yahoo Finance

from "phlebotomist" - Google News https://yhoo.it/3w1vcTg

No comments:

Post a Comment